Macrophage-centered therapy strategies: A promising weapon in cancer immunotherapy
Simiao Wang, Jiayi Liu, Yaxin Cui, Man Sun, Wei Wang, Jiayi Chen, Jingkai Gu, Zhaogang Yang
Jilin University University of Bergen
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Macrophages are critical phagocytes in the immune system, and tumor-infiltrating macrophages can substantially influence the efficacy and prognosis of immunotherapy. Therefore, macrophages may serve as therapeutic targets for modulating the tumor immune microenvironment. Macrophage-based drug delivery systems have been extensively evaluated owing to their excellent biocompatibility, long half-life, and inherent ability to migrate and accumulate at sites of inflammation, such as tumors. Live macrophages and their membrane coatings contain abundant receptor proteins that facilitate payload transport across physiological barriers. In this review, we discuss strategies that utilize macrophages as targets and delivery carriers for cancer immunotherapy. Here, we summarize the different macrophage phenotypes, tumor-associated macrophage-targeting strategies, and biomimetic delivery carriers derived from macrophages used in immunotherapy. Overall, macrophage-centered strategies for cancer therapy hold considerable promise for clinical applications. Therapeutic strategies targeting TAMs are regarded as one of the most promising research strategies against tumor. At present, strategies for targeting TAM mainly include the inhibition of “don't eat me” signaling at phagocytic checkpoints, inhibition of macrophage recruitment, depletion of TAMs and reprograming TAMs in TME.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Immune cells in cancer
Cancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses
参考文献 267
此处列出前 3 条
引用本文 18
按被引量排序,此处列出前 3 条